Zobrazeno 1 - 10
of 6 100
pro vyhledávání: '"Neoadjuvant chemoradiotherapy"'
Autor:
Yunsong Liu, Yi Wang, Xinyang Hu, Xin Wang, Liyan Xue, Qingsong Pang, Huan Zhang, Zeliang Ma, Heping Deng, Zhaoyang Yang, Xujie Sun, Yu Men, Feng Ye, Kuo Men, Jianjun Qin, Nan Bi, Jing Zhang, Qifeng Wang, Zhouguang Hui
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Objectives This study aimed to develop and validate a deep-learning radiomics model using CT, T2, and DWI images for predicting pathological complete response (pCR) in patients with esophageal squamous cell carcinoma (ESCC) undergoing neoadj
Externí odkaz:
https://doaj.org/article/e3b7b1b74d104b0293b1de1eb460ecdf
Autor:
Shuming Shi, Hao Zhou, Li Li, Fuhao Xu, Ning Liu, Dexian Zhang, Xiaohui Xu, Yawen Sun, Shuanghu Yuan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Background: Neoadjuvant chemoradiotherapy combined with immunotherapy (NICRT) is a new neoadjuvant treatment approach that has raised concerns regarding potential challenges in surgery and postoperative complications. This study aimed to com
Externí odkaz:
https://doaj.org/article/1765c2ce883249b591a548271feb152a
Autor:
Ji Ha Lim, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Jung Kyong Shin
Publikováno v:
BMC Surgery, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background To prevent local recurrence caused by exfoliated cancer cells caught in the suture line, intraoperative rectal washout during surgery can be performed to eliminate exfoliated cancer cells. However, the impact of neoadjuvant chemor
Externí odkaz:
https://doaj.org/article/c67887accdbe46968a52c4118a4cda17
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background In locally advanced, operable esophageal squamous cell carcinoma (ESCC), neoadjuvant immunochemotherapy (nICT) has shown results that are somewhat comparable to those of standard neoadjuvant chemoradiotherapy (nCRT). The impact of
Externí odkaz:
https://doaj.org/article/d62ea1a408bf481c92f408bc53a0191f
Autor:
Siyuan Qin, Ke Liu, Yongye Chen, Yan Zhou, Weili Zhao, Ruixin Yan, Peijin Xin, Yupeng Zhu, Hao Wang, Ning Lang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Establishing predictive models for the pathological response and lymph node metastasis in locally advanced rectal cancer (LARC) treated with neoadjuvant chemoradiotherapy (nCRT) based on MRI radiomic features derived from the tumor and mesor
Externí odkaz:
https://doaj.org/article/0e4e99b0e17c4ea78ae9a77a48d578f1
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background To compare the difference of postoperative anastomotic leakage (AL) rate between neoadjuvant chemoradiotherapy (NCRT) with pembrolizumab and NCRT group, and investigate the risk factors of developing AL for locally advanced esopha
Externí odkaz:
https://doaj.org/article/4531bb5ebc844e9dbd92199418fa6a05
Autor:
Xiangwen Tan, Yiwei Zhang, Xiaofeng Wu, Qing Fang, Yunhua Xu, Shuxiang Li, Jinyi Yuan, Xiuda Peng, Kai Fu, Shuai Xiao
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Neoadjuvant chemoradiotherapy (NCRT) followed by total mesorectal excision (TME) is the standard treatment for locally advanced rectal cancer (LARC). Mucinous adenocarcinoma (MAC) is a potential poor prognosis subgroup of rectal c
Externí odkaz:
https://doaj.org/article/9e4e8c3499044c05aaa509ff3b90242f
Autor:
Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Jun Zhang, Lin Peng, Qifeng Wang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Many patients undergo dose reduction or early termination of chemotherapy to reduce chemoradiotherapy-related toxicity, which may increase their risk of survival. However, this strategy may result in underdosing patients with loca
Externí odkaz:
https://doaj.org/article/f8acfde563f240ffb6d95e9f14696d21
Publikováno v:
Diagnostic and Interventional Radiology, Vol 30, Iss 4, Pp 228-235 (2024)
PURPOSE: Non-invasive methods for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) can provide distinct leverage in the management of patients with locally advanced rectal cancer (LARC). This study aimed to i
Externí odkaz:
https://doaj.org/article/116afea1a91f441ebd13ebaa77fea3ef
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background To explore the correlation between effective dose to immune cells (EDIC) and vertebral bone marrow dose and hematologic toxicity (HT) for esophageal squamous cell carcinoma (ESCC) during neoadjuvant chemoradiotherapy (nCRT). Metho
Externí odkaz:
https://doaj.org/article/7effd1dd9f684702a79559d42e1a9734